GSK Services Sp. z o.o. secures contract for Pharmaceutical products - Belantamab mafodotin as part of the implementation of the B54 Drug Program Treatment of patients with multiple myeloma - 1 assortment package

Poland, Sept. 2 -- Poland based GSK Services Sp. z o.o. has secured contract from UNIWERSYTECKI SZPITAL KLINICZNY W POZNANIU for Pharmaceutical products - Belantamab mafodotin as part of the implementation of the B54 Drug Program Treatment of patients with multiple myeloma - 1 assortment package. The value of the contract is worth 22655500 PLN.

Published by HT Digital Content Services with permission from Pivotal Sources....